申请人:CHOI Seok-Ki
公开号:US20100267788A1
公开(公告)日:2010-10-21
The invention is directed to compounds of formula I:
wherein Ar, r, R
3
, X, and R
5-7
are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula I have AT
1
receptor antagonist activity and neprilysin inhibition activity. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and a process and intermediates for preparing such compounds.
本发明涉及式I的化合物:其中Ar、r、R3、X和R5-7如规范所定义,并且其药学上可接受的盐。式I的化合物具有AT1受体拮抗活性和酰肽酶抑制活性。本发明还涉及包含这些化合物的制药组合物;使用这些化合物的方法;以及制备这些化合物的过程和中间体。